{"id":"https://openalex.org/W2529944890","doi":"https://doi.org/10.1182/blood.v118.21.261.261","title":"A Somatic Variant in MYD88 (L265P) Revealed by Whole Genome Sequencing Differentiates Lymphoplasmacytic Lymphoma From Marginal Zone Lymphomas","display_name":"A Somatic Variant in MYD88 (L265P) Revealed by Whole Genome Sequencing Differentiates Lymphoplasmacytic Lymphoma From Marginal Zone Lymphomas","publication_year":2011,"publication_date":"2011-11-18","ids":{"openalex":"https://openalex.org/W2529944890","doi":"https://doi.org/10.1182/blood.v118.21.261.261","mag":"2529944890"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v118.21.261.261","doi":"https://doi.org/10.1182/blood.v118.21.261.261","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v118.21.261.261","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110212228","display_name":"Lian Xu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Lian Xu","raw_affiliation_strings":["Bing Center for Waldenstrom's Macroglobulinemia, Dana Farber Cancer Institute, Boston, MA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bing Center for Waldenstrom's Macroglobulinemia, Dana Farber Cancer Institute, Boston, MA, USA,","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087751610","display_name":"Aliyah R. Sohani","orcid":"https://orcid.org/0000-0002-6307-4854","observed_orcids":["https://orcid.org/0000-0002-6307-4854"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aliyah R. Sohani","raw_affiliation_strings":["Pathology, Maasachusetts General Hospital, Boston, MA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pathology, Maasachusetts General Hospital, Boston, MA, USA,","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019034145","display_name":"Luca Arcaini","orcid":"https://orcid.org/0000-0002-9504-991X","observed_orcids":["https://orcid.org/0000-0002-9504-991X"]},"institutions":[{"id":"https://openalex.org/I25217355","display_name":"University of Pavia","ror":"https://ror.org/00s6t1f81","country_code":"IT","type":"education","lineage":["https://openalex.org/I25217355"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Luca Arcaini","raw_affiliation_strings":["Division of Hematology, University of Pavia, Pavia, Italy,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology, University of Pavia, Pavia, Italy,","institution_ids":["https://openalex.org/I25217355"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026121534","display_name":"Zachary R. Hunter","orcid":"https://orcid.org/0000-0002-1689-1691","observed_orcids":["https://orcid.org/0000-0002-1689-1691"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Zachary Hunter","raw_affiliation_strings":["Bing Center for Waldenstrom\u2018s Macroglobulinemia, Dana Farber Cancer Institute, Boston, MA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bing Center for Waldenstrom\u2018s Macroglobulinemia, Dana Farber Cancer Institute, Boston, MA, USA,","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089994476","display_name":"Guang Yang","orcid":"https://orcid.org/0000-0003-3049-4200","observed_orcids":["https://orcid.org/0000-0003-3049-4200"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Guang Yang","raw_affiliation_strings":["Bing Center for Waldenstro\u0308m's Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bing Center for Waldenstro\u0308m's Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA, USA,","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102145648","display_name":"Yangsheng Zhou","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Yangsheng Zhou","raw_affiliation_strings":["Bing Center for Waldenstrom's Macroglobulinemia, Dana Farber Cancer Institute, Boston, MA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bing Center for Waldenstrom's Macroglobulinemia, Dana Farber Cancer Institute, Boston, MA, USA,","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100373208","display_name":"Xia Liu","orcid":"https://orcid.org/0000-0001-7599-6285","observed_orcids":["https://orcid.org/0000-0001-7599-6285"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Xia Liu","raw_affiliation_strings":["Bing Center for Waldenstrom's Macroglobulinemia, Dana Farber Cancer Institute, Boston, MA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bing Center for Waldenstrom's Macroglobulinemia, Dana Farber Cancer Institute, Boston, MA, USA,","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014323068","display_name":"Yang Cao","orcid":"https://orcid.org/0000-0002-0058-614X","observed_orcids":["https://orcid.org/0000-0002-0058-614X","https://orcid.org/0009-0009-9165-7297"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Yang Cao","raw_affiliation_strings":["Bing Center for Waldenstrom's Macroglobulinemia, Dana Farber Cancer Institute, Boston, MA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bing Center for Waldenstrom's Macroglobulinemia, Dana Farber Cancer Institute, Boston, MA, USA,","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013473678","display_name":"Robert R Manning","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Robert Manning","raw_affiliation_strings":["Bing Center for Waldenstrom's Macroglobulinemia, Dana Farber Cancer Institute, Boston, MA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bing Center for Waldenstrom's Macroglobulinemia, Dana Farber Cancer Institute, Boston, MA, USA,","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031106919","display_name":"Christopher J. Patterson","orcid":"https://orcid.org/0000-0002-9652-2203","observed_orcids":["https://orcid.org/0000-0002-9652-2203"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Christopher J Patterson","raw_affiliation_strings":["Waldenstrom's macroglubulinemia center, Dana-Farber Cancer Institute, Boston, MA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Waldenstrom's macroglubulinemia center, Dana-Farber Cancer Institute, Boston, MA, USA,","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112254498","display_name":"Leukothea Ioakimidis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Leukothea Ioakimidis","raw_affiliation_strings":["Bing Center for Waldenstrom's Macroglobulinemia, Dana Farber Cancer Institute, Boston, MA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bing Center for Waldenstrom's Macroglobulinemia, Dana Farber Cancer Institute, Boston, MA, USA,","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011228203","display_name":"Christina K. Tripsas","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Christina Tripsas","raw_affiliation_strings":["Bing Center for Waldenstrom's Macroglobulinemia, Dana Farber Cancer Institute, Boston, MA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bing Center for Waldenstrom's Macroglobulinemia, Dana Farber Cancer Institute, Boston, MA, USA,","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112148042","display_name":"Geraldine S. Pinkus","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Geraldine S. Pinkus","raw_affiliation_strings":["Pathology Department, Brigham And Women's Hospital, Boston, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pathology Department, Brigham And Women's Hospital, Boston, USA,","institution_ids":["https://openalex.org/I1283280774"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019589864","display_name":"Nancy L. Harris","orcid":"https://orcid.org/0000-0001-6661-4249","observed_orcids":["https://orcid.org/0000-0001-6661-4249"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nancy Lee Harris","raw_affiliation_strings":["Massachusetts General Hospital, Waban, MA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital, Waban, MA, USA,","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058975989","display_name":"Scott J. Rodig","orcid":"https://orcid.org/0000-0003-1761-9769","observed_orcids":["https://orcid.org/0000-0003-1761-9769"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Scott J. Rodig","raw_affiliation_strings":["Pathology, Brigham & Women's Hospital, Harvard Medical School, Boston, MA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pathology, Brigham & Women's Hospital, Harvard Medical School, Boston, MA, USA,","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5081299017","display_name":"Steven Peter Treon","orcid":"https://orcid.org/0000-0001-6393-6154","observed_orcids":["https://orcid.org/0000-0001-6393-6154"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Steven Treon","raw_affiliation_strings":["Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5011228203","https://openalex.org/A5013473678","https://openalex.org/A5014323068","https://openalex.org/A5019034145","https://openalex.org/A5026121534","https://openalex.org/A5031106919","https://openalex.org/A5089994476","https://openalex.org/A5100373208","https://openalex.org/A5102145648","https://openalex.org/A5110212228","https://openalex.org/A5112148042","https://openalex.org/A5112254498"],"corresponding_institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I25217355","https://openalex.org/I4210117453"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":2.3318,"has_fulltext":false,"cited_by_count":13,"citation_normalized_percentile":{"value":0.88065699,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"118","issue":"21","first_page":"261","last_page":"261"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9839000105857849,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9839000105857849,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.014100000262260437,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12212","display_name":"CNS Lymphoma Diagnosis and Treatment","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/lymphoplasmacytic-lymphoma","display_name":"lymphoplasmacytic lymphoma","score":0.9549999833106995},{"id":"https://openalex.org/keywords/marginal-zone-lymphoma","display_name":"marginal zone lymphoma","score":0.9959999918937683},{"id":"https://openalex.org/keywords/somatic-mutations","display_name":"somatic mutations","score":0.7020000219345093},{"id":"https://openalex.org/keywords/molecular-markers","display_name":"molecular markers","score":0.3449999988079071},{"id":"https://openalex.org/keywords/waldenstrom-macroglobulinemia","display_name":"Waldenstr\u00f6m macroglobulinemia","score":0.9160000085830688},{"id":"https://openalex.org/keywords/splenic-marginal-zone-lymphoma","display_name":"splenic marginal zone lymphoma","score":0.8679999709129333},{"id":"https://openalex.org/keywords/malt-lymphoma","display_name":"MALT lymphoma","score":0.9409999847412109},{"id":"https://openalex.org/keywords/nodal-marginal-zone-lymphoma","display_name":"nodal marginal zone lymphoma","score":0.9670000076293945},{"id":"https://openalex.org/keywords/nf-kappab-signaling","display_name":"NF-\u03baB signaling","score":0.7670000195503235},{"id":"https://openalex.org/keywords/monoclonal-igm","display_name":"monoclonal IgM","score":0.5680000185966492}],"concepts":[{"id":"https://openalex.org/C2910423619","wikidata":"https://www.wikidata.org/wiki/Q1778287","display_name":"Lymphoplasmacytic Lymphoma","level":4,"score":0.8826745748519897},{"id":"https://openalex.org/C2779380147","wikidata":"https://www.wikidata.org/wiki/Q3832900","display_name":"Splenic marginal zone lymphoma","level":4,"score":0.7394727468490601},{"id":"https://openalex.org/C2779921676","wikidata":"https://www.wikidata.org/wiki/Q6760434","display_name":"Marginal zone","level":4,"score":0.6091995239257812},{"id":"https://openalex.org/C2781038049","wikidata":"https://www.wikidata.org/wiki/Q1778287","display_name":"Waldenstrom macroglobulinemia","level":3,"score":0.6024760007858276},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5934684872627258},{"id":"https://openalex.org/C2778563104","wikidata":"https://www.wikidata.org/wiki/Q18553449","display_name":"Marginal zone B-cell lymphoma","level":5,"score":0.5560024380683899},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.5097400546073914},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.499553918838501},{"id":"https://openalex.org/C2776391228","wikidata":"https://www.wikidata.org/wiki/Q4118092","display_name":"Macroglobulinemia","level":3,"score":0.43958500027656555},{"id":"https://openalex.org/C2779526237","wikidata":"https://www.wikidata.org/wiki/Q591256","display_name":"MALT lymphoma","level":3,"score":0.43874645233154297},{"id":"https://openalex.org/C2778559949","wikidata":"https://www.wikidata.org/wiki/Q2626074","display_name":"Diffuse large B-cell lymphoma","level":3,"score":0.42955392599105835},{"id":"https://openalex.org/C13514818","wikidata":"https://www.wikidata.org/wiki/Q5552256","display_name":"Germline mutation","level":4,"score":0.4192071855068207},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.41543838381767273},{"id":"https://openalex.org/C2778453870","wikidata":"https://www.wikidata.org/wiki/Q188930","display_name":"B cell","level":3,"score":0.36649274826049805},{"id":"https://openalex.org/C501734568","wikidata":"https://www.wikidata.org/wiki/Q42918","display_name":"Mutation","level":3,"score":0.2875385880470276},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.2534235715866089},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.21479320526123047},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.20436730980873108},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.17573803663253784},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.16444724798202515},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.15629002451896667}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v118.21.261.261","doi":"https://doi.org/10.1182/blood.v118.21.261.261","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v118.21.261.261","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9537000060081482}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1930172328","https://openalex.org/W2805225803","https://openalex.org/W2038370829","https://openalex.org/W7163815443","https://openalex.org/W2133493478","https://openalex.org/W2067907405","https://openalex.org/W2587144756","https://openalex.org/W2115093629","https://openalex.org/W2060074323","https://openalex.org/W2979698757"],"abstract_inverted_index":{"Abstract":[0,1],"261":[2],"Lymphoplasmacytic":[3],"(LPL)":[4],"and":[5,37,100,138,152,192,200,221,256,272,301,318,359],"marginal":[6],"zone":[7],"lymphoma":[8],"(MZL)":[9],"are":[10],"distinct":[11],"clinicopathological":[12,320],"entities":[13],"under":[14],"the":[15,93,237,264,293,327,348],"WHO":[16],"classification":[17],"system":[18],"for":[19],"B-cell":[20],"lymphomas.":[21],"Differentiation":[22],"of":[23,117,135,145,150,154,173,185,263,343,377,388],"LPL":[24,50,62,119,235,276,365],"from":[25,54,60,90,110,143,179,230,246,336,366],"MZL":[26,285],"has":[27],"been":[28],"difficult":[29],"due":[30],"to":[31,43,69,112,166,363],"overlapping":[32],"clinical,":[33],"morphological,":[34],"histopathological,":[35],"immunophenotypic,":[36],"cytogenetic":[38],"features.":[39],"We":[40],"therefore":[41,194],"sought":[42],"identify":[44,70],"a":[45,76,86,101,314],"molecular":[46],"marker":[47],"by":[48],"which":[49,213,250,297],"could":[51],"be":[52,361],"differentiated":[53],"MZL.":[55,367],"Using":[56],"paired":[57],"normal/tumor":[58],"tissues":[59],"10":[61,116,118],"patients,":[63,236],"whole":[64],"genome":[65],"sequencing":[66,172],"was":[67,241,268,298,331],"utilized":[68],"somatic":[71,77],"variants.":[72],"These":[73],"studies":[74],"identified":[75],"variant":[78,240,267,296,330],"at":[79,105],"position":[80,108],"38182641":[81],"in":[82,92,115,128,141,175,243,270,274,333,355],"chromosome":[83],"3p22.2":[84],"with":[85,147,156,182,202,208,211,254,259,284,309,323,357],"single":[87],"nucleotide":[88],"change":[89,104],"T\u2192C":[91],"myeloid":[94],"differentiation":[95],"primary":[96],"response":[97],"(MYD88)":[98],"gene,":[99],"predicted":[102],"non-synonymous":[103],"amino":[106],"acid":[107],"265":[109],"leucine":[111],"proline":[113],"(L265P)":[114],"patients.":[120,277],"MYD88":[121,174,238,265,294,328,349],"L265P":[122,239,266,295,329,350],"is":[123,139,352],"an":[124,188,203,374,385],"oncogenically":[125],"active":[126],"mutation":[127,351],"DLBCL":[129],"ABC":[130,148],"cell":[131],"lines":[132],"via":[133],"activation":[134],"IRAK1/4/TRAF-6/NF-\u03ba\u03b2":[136],"signaling,":[137],"present":[140],"tumors":[142],"29%":[144],"patients":[146,155,181,210,253,258,283,304,356],"subtype":[149],"DLBCL,":[151],"6%":[153],"MALT":[157],"lymphomas":[158],"(Ngo":[159],"et":[160],"al,":[161],"Nature":[162],"2011,":[163],"470:115\u2013119).":[164],"Further":[165],"these":[167],"efforts,":[168],"we":[169],"performed":[170],"Sanger":[171],"malignant":[176,244],"cells":[177,245,335],"obtained":[178],"51":[180],"LPL,":[183,358],"49":[184],"whom":[186],"had":[187],"IgM":[189,316],"monoclonal":[190,205,315],"protein":[191],"were":[193],"classified":[195],"as":[196,226,228],"Waldenstrom's":[197],"Macroglobulinemia":[198],"(WM),":[199],"2":[201,257,303],"IgG":[204,260],"protein,":[206,317],"along":[207],"46":[209],"MZL,":[212],"included":[214,251,302],"21":[215],"Splenic":[216],"(SMZL),":[217],"20":[218],"Extranodal":[219],"(EMZL),":[220],"5":[222],"Nodal":[223],"(NMZL)":[224],"Subtypes,":[225],"well":[227],"B-cells":[229],"15":[231,338],"healthy":[232,339],"donors.":[233,340],"Among":[234],"found":[242],"46/51":[247],"(90.1%)":[248],"cases,":[249],"44":[252],"WM,":[255],"LPL.":[261,324],"Expression":[262],"heterozygous":[269,299],"42,":[271],"homozygous":[273],"4":[275],"By":[278,325],"comparison,":[279,326],"only":[280],"3/46":[281],"(6.5%)":[282],"(1":[286,305],"SMZL;":[287],"1":[288,290,307],"EMZL;":[289],"NMZL)":[291,308],"exhibited":[292],"(p<0.0001),":[300],"SMZL,":[306],"extensive":[310],"bone":[311],"marrow":[312],"involvement,":[313],"whose":[319],"characteristics":[321],"overlapped":[322],"absent":[332],"CD19+":[334],"all":[337],"The":[341],"results":[342],"this":[344],"study":[345],"demonstrate":[346],"that":[347],"widely":[353],"expressed":[354],"can":[360],"used":[362],"differentiate":[364],"Disclosures:":[368],"Treon:":[369],"Millennium:":[370],"Consultancy,":[371],"Membership":[372,383],"on":[373,384],"entity's":[375,386],"Board":[376,387],"Directors":[378,389],"or":[379,390],"advisory":[380,391],"committees;":[381],"Celgene:":[382],"committees.":[392]},"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2013,"cited_by_count":5},{"year":2012,"cited_by_count":6}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-10-21T00:00:00"}